280 related articles for article (PubMed ID: 17190526)
1. Neurotensin agonists: potential in the treatment of schizophrenia.
Boules M; Shaw A; Fredrickson P; Richelson E
CNS Drugs; 2007; 21(1):13-23. PubMed ID: 17190526
[TBL] [Abstract][Full Text] [Related]
2. Novel treatments of schizophrenia: targeting the neurotensin system.
Kinkead B; Nemeroff CB
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):205-18. PubMed ID: 16611093
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin agonists as an alternative to antipsychotics.
Boules M; Fredrickson P; Richelson E
Expert Opin Investig Drugs; 2005 Apr; 14(4):359-69. PubMed ID: 15882113
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin, schizophrenia, and antipsychotic drug action.
Kinkead B; Nemeroff CB
Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
Stowe ZN; Bissette G; Nemeroff CB
Yakubutsu Seishin Kodo; 1991 Feb; 11(1):49-59. PubMed ID: 1679273
[TBL] [Abstract][Full Text] [Related]
6. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Biol Psychiatry; 2001 Dec; 50(11):856-72. PubMed ID: 11743941
[TBL] [Abstract][Full Text] [Related]
7. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
Cáceda R; Kinkead B; Nemeroff CB
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins.
Griebel G
Curr Pharm Des; 2015; 21(26):3807-12. PubMed ID: 26044977
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin: an endogenous antipsychotic?
Kinkead B; Nemeroff CB
Curr Opin Pharmacol; 2002 Feb; 2(1):99-103. PubMed ID: 11786316
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders.
Boules MM; Fredrickson P; Muehlmann AM; Richelson E
Behav Sci (Basel); 2014 Jun; 4(2):125-153. PubMed ID: 25379273
[TBL] [Abstract][Full Text] [Related]
11. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.
Sharma RP; Janicak PG; Bissette G; Nemeroff CB
Am J Psychiatry; 1997 Jul; 154(7):1019-21. PubMed ID: 9210757
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
13. Bioactive analogs of neurotensin: focus on CNS effects.
Boules M; Fredrickson P; Richelson E
Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
[TBL] [Abstract][Full Text] [Related]
14. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.
Kasckow J; Nemeroff CB
Regul Pept; 1991 Oct; 36(2):153-64. PubMed ID: 1666685
[TBL] [Abstract][Full Text] [Related]
15. Does neurotensin mediate the effects of antipsychotic drugs?
Kinkead B; Binder EB; Nemeroff CB
Biol Psychiatry; 1999 Aug; 46(3):340-51. PubMed ID: 10435199
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin analogs indications for use as potential antipsychotic compounds.
McMahon BM; Boules M; Warrington L; Richelson E
Life Sci; 2002 Jan; 70(10):1101-19. PubMed ID: 11848295
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
[TBL] [Abstract][Full Text] [Related]
18. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects.
Feifel D; Melendez G; Shilling PD
Neuropsychopharmacology; 2004 Apr; 29(4):731-8. PubMed ID: 14760394
[TBL] [Abstract][Full Text] [Related]
19. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
Kinkead B; Nemeroff CB
J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
[TBL] [Abstract][Full Text] [Related]
20. Neurotensin receptor agonists and antagonists for schizophrenia.
Richelson E; Fredrickson PA; Boules MM
Am J Psychiatry; 2005 Mar; 162(3):633-4; author reply 635. PubMed ID: 15741499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
